BRIEF published on 08/02/2024 at 22:35, 1 year 7 months ago DBV Technologies : Informations au 31 juillet 2024 sur le nombre d'actions et de droits de vote Droits De Vote Capital Social AMF DBV Technologies NYSE Euronext Paris
BRIEF published on 08/02/2024 at 22:35, 1 year 7 months ago DBV Technologies: Information as of July 31, 2024 on the number of shares and voting rights Share Capital Voting Rights AMF DBV Technologies NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 1 year 7 months ago Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2024 Nombre total des droits de vote et d’actions au 31 juillet 2024 pour NYSE Euronext Paris (Code ISIN: FR 0010417345) : 96 498 927 actions, 96 214 457 droits de vote Autorité Des Marchés Financiers Droits De Vote Capital Social Actions NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 1 year 7 months ago Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 Details of total voting rights and shares of the Company as of July 31, 2024 under AMF regulations Voting Rights Shares AMF Regulations Company July 31 2024
BRIEF published on 07/30/2024 at 23:35, 1 year 7 months ago DBV Technologies met à disposition son Rapport Financier Semestriel 2024 AMF Rapport Financier DBV Technologies Allergies Alimentaires Viaskin™
BRIEF published on 07/30/2024 at 23:35, 1 year 7 months ago DBV Technologies makes its 2024 Half-Year Financial Report available AMF Financial Report DBV Technologies Food Allergy Viaskin™
PRESS RELEASE published on 07/30/2024 at 23:30, 1 year 7 months ago DBV Technologies publie son Rapport Financier Semestriel 2024 ? Modalités de mise à disposition ou de consultation DBV Technologies publie son Rapport Financier Semestriel 2024 et annonce sa disponibilité pour consultation en ligne ou par demande Biopharmaceutique Rapport Financier DBV Technologies Allergies Alimentaires Viaskin
PRESS RELEASE published on 07/30/2024 at 23:30, 1 year 7 months ago DBV Technologies Announces Filing of 2024 Half-Year Report ? Conditions for Accessing or Consulting the Report DBV Technologies files 2024 Half-Year Report with AMF and offers access via website or request. Company develops treatments for food allergies using Viaskin platform AMF DBV Technologies Food Allergies 2024 Half-Year Report Viaskin Platform
BRIEF published on 07/30/2024 at 22:35, 1 year 7 months ago DBV Technologies : Avancées pour Viaskin Peanut et résultats financiers au premier semestre 2024 Résultats Financiers Recherche Et Développement DBV Technologies Allergies Alimentaires Viaskin Peanut
Published on 03/24/2026 at 10:10, 1 hour 48 minutes ago BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform
Published on 03/24/2026 at 08:01, 3 hours 57 minutes ago Star Copper Confirms Copper Creek Mineralization
Published on 03/24/2026 at 07:00, 4 hours 58 minutes ago Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 4 hours 58 minutes ago Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/24/2026 at 11:45, 13 minutes ago BIOTRONIK Leaps Forward with Next‑Generation Leadless Pacing
Published on 03/24/2026 at 11:32, 26 minutes ago Correction of a release from 24.03.2026 08:00 GMT/BST - official list notice
Published on 03/24/2026 at 11:30, 28 minutes ago Infosys and University of Nottingham Extend Strategic Collaboration to Strengthen Digital Infrastructure for Student Management System
Published on 03/24/2026 at 11:20, 38 minutes ago EQS-Adhoc: Leifheit Aktiengesellschaft: Dividend Proposal and Forecast for Financial Year 2026
Published on 03/24/2026 at 11:16, 42 minutes ago Original-Research: Vossloh AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Published on 03/24/2026 at 10:58, 1 hour ago Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 1 hour ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 4 hours 13 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 4 hours 13 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 4 hours 28 minutes ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
